 | • レポートコード：TPM-B04246 • 出版社/出版日：Transparency Market Research / 2018年3月 • レポート形態：英文、PDF、162ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、髄膜炎診断検査の世界市場について調べ、髄膜炎診断検査の世界規模、市場動向、市場環境、製品別分析、産業別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・髄膜炎診断検査の世界市場動向 ・髄膜炎診断検査の世界市場環境 ・髄膜炎診断検査の世界市場規模 ・髄膜炎診断検査の世界市場規模：製品別 ・髄膜炎診断検査の世界市場規模：産業別 ・髄膜炎診断検査の世界市場：地域別市場規模・分析 ・髄膜炎診断検査の北米市場規模・予測 ・髄膜炎診断検査のアメリカ市場規模・予測 ・髄膜炎診断検査の中南米市場規模・予測 ・髄膜炎診断検査のヨーロッパ市場規模・予測 ・髄膜炎診断検査のアジア市場規模・予測 ・髄膜炎診断検査の中東市場規模・予測 ・髄膜炎診断検査のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Meningitis Diagnostic Testing Market: Overview
This report on meningitis diagnostic testing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing diagnostic test for meningitis as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the global meningitis diagnostic testing market with respect to the leading market segments based on product type, end-user and geographies.
Meningitis Diagnostic Testing Market: Segmentations
The global meningitis diagnostic testing market is divided into three segments: by product, by end user and by geography. Based on the product, the market has been further segmented into six major sub segments latex agglutination tests, lateral flow assay, PCR assay, ELISA tests, culture test, and others. The market has been further studied from the point of view of end user. Based on end user, the market has been segmented into hospitals, diagnostics centers and others
Each of the market segments have been extensively analyzed based on the market related factors such as increase incidence of meningitis and available testing options. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the meningitis diagnostic testing market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global meningitis diagnostic testing market.
Geographically, meningitis diagnostic testing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global meningitis diagnostic testing market.
Meningitis Diagnostic Testing Market: Competitive Landscape
Major players operating in the global meningitis diagnostic testing market are Thermo Fisher Scientific, Inc., Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers, Bio-Rad Laboratories, Inc., IMMY, BioFire Diagnostics, Nanosphere (Luminex Corporation), Seegene Inc., Qnostics, ELITechGroup, and Abbott Laboratories exhibit the largest geographical outreach with presence in multiple meningitis diagnostic testing products
The global meningitis diagnostic testing market is segmented as follows:
Global Meningitis Diagnostic Testing Market Revenue, by Product
Latex Agglutination Tests
Lateral Flow Assay
PCR Assay
ELISA Tests
Culture Test
Others
Global Meningitis Diagnostic Testing Market Revenue, by End User
Hospital
Diagnostic Centers
Others
Global Meningitis Diagnostic Testing Market Revenue, by Geography
North America
U.S.
Canada
Europe
Germany
France
Italy
Spain
U.K.
Rest of Europe
Asia Pacific
India
Japan
China
Australia & New Zealand
Rest of Asia
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & Africa
Middle East & North Africa
Sub-Saharan Africa
Rest of Middle East & Africa
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Meningitis Diagnostic Testing Market Snapshot
4. Market Overview
4.1. Product Overview
4.2. Key Industry Events
4.3. Global Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, 2015-2025
4.4. Market Opportunity Map
4.5. Porter’s Analysis
4.6. Global Meningitis Diagnostic Testing Market Outlook
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Trends
5.1. Key Success factor for Top Players
5.2. Key Mergers and Acquisitions-In vitro Diagnostics (IVD) Industry
5.3. Regulatory Scenario
6. Global Meningitis Diagnostic Testing Market Analysis, by Product
6.1. Introduction
6.2. Key Findings
6.3. Global Meningitis Diagnostic Testing Market Value Share, by Product
6.4. Global Meningitis Diagnostic Testing Market Forecast, by Product
6.4.1. Latex Agglutination Tests
6.4.2. Lateral Flow Assay
6.4.3. PCR Assay
6.4.4. ELISA Tests
6.4.5. Culture Test
6.4.6. Others
6.5. Global Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product
7. Global Meningitis Diagnostics Testing Market Analysis, by End User
7.1. Introduction
7.2. Key Findings
7.3. Global Meningitis Diagnostic Testing Market Value Share Analysis, by End User
7.4. Global Meningitis Diagnostic Testing Market Forecast, by End User
7.4.1. Hospital
7.4.2. Diagnostic Center
7.4.3. Others
7.5. Global Meningitis Diagnostic Testing Market Attractiveness Analysis, by End User
8. Global Meningitis Diagnostic Testing Market Analysis, by Region
8.1. Global Market Scenario by Country
8.2. Global Meningitis Diagnostic Testing Market Value Share Analysis, by Region
8.3. Global Meningitis Diagnostic Testing Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4. Global Meningitis Diagnostic Testing Attractiveness Analysis By Region
9. North America Meningitis Diagnostic Testing Market Analysis
9.1. Key Findings
9.2. Market Overview
9.3. North America Meningitis Diagnostic Testing Market Value Share Analysis, by Country
9.4. North America Meningitis Diagnostic Testing Market Forecast, by Country
9.5. North America Meningitis Diagnostic Testing Market Value Share Analysis, by Product
9.6. North America Meningitis Diagnostic Testing Market Forecast, by Product
9.6.1. Latex Agglutination Tests
9.6.2. Lateral Flow Assay
9.6.3. PCR Assay
9.6.4. ELISA Tests
9.6.5. Culture Test
9.6.6. Others
9.7. North America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
9.8. North America Meningitis Diagnostic Testing Market Forecast, by End-user
9.8.1. Hospital
9.8.2. Diagnostic Center
9.8.3. Others
9.9. North America Meningitis Diagnostic Testing Market Attractiveness Analysis
10. Europe Meningitis Diagnostic Testing Market Analysis
10.1. Key Findings
10.2. Market Overview
10.3. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Country
10.4. Europe Meningitis Diagnostic Testing Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Product
10.6. Europe Meningitis Diagnostic Testing Market Forecast, by Product
10.6.1. Latex Agglutination Tests
10.6.2. Lateral Flow Assay
10.6.3. PCR Assay
10.6.4. ELISA Tests
10.6.5. Culture Test
10.6.6. Others
10.7. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
10.8. Europe Meningitis Diagnostic Testing Market Forecast, by End-user
10.8.1. Hospital
10.8.2. Diagnostic Center
10.8.3. Others
10.9. Europe Meningitis Diagnostic Testing Market Attractiveness Analysis
11. Asia Pacific Meningitis Diagnostic Testing Market Analysis
11.1. Key Findings
11.2. Market Overview
11.3. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Country
11.4. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by Country
11.4.1. U.K.
11.4.2. Germany
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest of Europe
11.5. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Product
11.6. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by Product
11.6.1. Latex Agglutination Tests
11.6.2. Lateral Flow Assay
11.6.3. PCR Assay
11.6.4. ELISA Tests
11.6.5. Culture Test
11.6.6. Others
11.7. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
11.8. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by End-user
11.8.1. Hospital
11.8.2. Diagnostic Center
11.8.3. Others
11.9. Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis
12. Latin America Meningitis Diagnostic Testing Market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Country
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Rest of Latin America
12.4. Latin America Meningitis Diagnostic Testing Market Forecast, by Country
12.5. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Product
12.6. Latin America Meningitis Diagnostic Testing Market Forecast, by Product
12.6.1. Latex Agglutination Tests
12.6.2. Lateral Flow Assay
12.6.3. PCR Assay
12.6.4. ELISA Tests
12.6.5. Culture Test
12.6.6. Others
12.7. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
12.8. Latin America Meningitis Diagnostic Testing Market Forecast, by End-user
12.8.1. Hospital
12.8.2. Diagnostic Center
12.8.3. Others
12.9. Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis
13. Middle East & Africa Meningitis Diagnostic Testing Market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Country
13.3.1. Middle East & North Africa
13.3.2. Sub-Saharan Africa
13.3.3. Rest of Africa
13.4. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by Country
13.5. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Product
13.6. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by Product
13.6.1. Latex Agglutination Tests
13.6.2. Lateral Flow Assay
13.6.3. PCR Assay
13.6.4. ELISA Tests
13.6.5. Culture Test
13.6.6. Others
13.7. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
13.8. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by End-user
13.8.1. Hospital
13.8.2. Diagnostic Center
13.8.3. Others
13.9. Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis
14. Competition Landscape
14.1. Meningitis Diagnostic Testing Market Share Analysis By Company, 2015
14.2. Competition Matrix
14.3. Company Profiles
14.3.1. Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers
14.3.1.1. Company Details
14.3.1.2. Business Overview
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Thermo Fisher Scientific, Inc.
14.3.2.1. Company Details
14.3.2.2. Business Overview
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.3. Abbott Laboratories.
14.3.3.1. Company Details
14.3.3.2. Business Overview
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.4. Bio-Rad Laboratories, Inc.
14.3.4.1. Company Details
14.3.4.2. Business Overview
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.5. Seegene Inc.
14.3.5.1. Company Details
14.3.5.2. Business Overview
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.6. DiagCor Bioscience Inc. Ltd
14.3.6.1. Company Details
14.3.6.2. Business Overview
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.7. BioFire Diagnostics (bioMerieux)
14.3.7.1. Company Details
14.3.7.2. Business Overview
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. IMMY
14.3.8.1. Company Details
14.3.8.2. Business Overview
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. Nanosphere (Luminex Corporation).
14.3.9.1. Company Details
14.3.9.2. Business Overview
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
TABLE 1 Global Meningitis Diagnostic Testing Market Value (US$ Mn) Forecast, by Product, 2015–2025
TABLE 2 Global Meningitis Diagnostic Testing Market Value (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 3 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
TABLE 4 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 5 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 6 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 7 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country /Sub-region, 2015–2025
TABLE 8 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 9 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 10 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 11 Table 11: Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 12 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 13 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 14 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 15 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 16 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 17 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 18 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 19 Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers Business Overview
TABLE 20 Thermo Fisher Scientific, Inc. Business Overview
TABLE 21 Abbott Laboratories Business Overview
TABLE 22 Bio-Rad Laboratories, Inc. Business Overview
TABLE 23 Seegene Inc. Business Overview
TABLE 24 DiagCor Bioscience Inc. Ltd Business Overview
TABLE 25 BioFire Diagnostics (bioMérieux) Business Overview
TABLE 26 IMMY Business Overview
TABLE 27 Nanosphere (Luminex Corporation) Business Overview